Trial Profile
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation (VF) or Ventricular Tachycardia (VT).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Dec 2021
Price :
$35
*
At a glance
- Drugs Amiodarone (Primary) ; Lidocaine
- Indications Heart arrest; Ventricular fibrillation; Ventricular tachycardia
- Focus Therapeutic Use
- Acronyms ALPS
- 15 Nov 2021 Results assessing utilize machine learning to construct predictive models of neurologically favorable survival in OHCA patients receiving standard ACLS and extracorporeal cardiopulmonary resuscitation (ECPR) presented at the American Heart Association Scientific Sessions 2021
- 13 Sep 2017 Results of a pre-specified analysis in patients with non-shockable OHCA (n=1063) published in the Circulation
- 29 Jan 2017 Status changed from active, no longer recruiting to completed.